Oxandroxyl 20 - Kalpa Pharmaceuticals

With its release in 1962, Oxandrolone entered the pharmaceutical landscape as a reliable anabolic therapy. Developed by G.D. Searle & Co. and sold as Anavar, the drug gained approval for use in treating muscle loss, delayed growth, and trauma recovery. Its structure provided anabolic effects without excessive masculinization, which made it suitable for women and children. After years of legitimate use, growing association with performance enhancement led to its removal in 1989. In 1995, it returned to the market as Oxandrin, with new regulatory oversight for rare medical applications.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandroxyl 20 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.